Loading search results
Sponsor study identifier
observational
200
1 country
1
Study Start
May 1, 2023
Actual (reported)Primary Completion
November 30, 2024
Actual (reported)Study Completion
July 30, 2025
Actual (reported)Currently, altered intestinal blood flow in critically ill patients has been a hot research topic in recent years. In 2022, studies on acute mesenteric ischemia were published in top journals in critical care medicine \[Crit Care, 2022. 26(1): p.92. and Intensive Care Med, 2022. 26(2): p.92.\]. However, because the gastrointestinal tract is in the abdominal cavity and doctors lack methods to directly monitor the visceral perfusion. Therefore, there is little research on the relationship between gastrointestinal perfusion and acute gastrointestinal injury in critical ill patients. Currently, the diagnosis of acute gastrointestinal injury is mostly performed using subjective indicators and adverse outcomes that have already occurred, which results in the treatment of acute gastrointestinal injury often lagging behind. The use of color Doppler ultrasonography to assess blood flow in intestinal vessels in healthy and outpatient patients has been in use since the 1980s. Our team showed that the resistance index of the superior mesenteric artery(SMA) in postoperative cardiac surgery patients correlated with lactate values and lactate clearance \[Front Med (Lausanne), 2021.8: p.762376.\], suggesting that gastrointestinal perfusion as reflected by SMA blood flow is important for systemic resuscitation, and that Doppler indices of SMA have the potential value of reflecting intestinal hypo-perfusion. Intestinal venous blood enters the portal vein and then the liver before returning to the right heart via the inferior vena cava. Right ventricular dysfunction or abdominal hypertension could cause obstruction of portal venous return, which might lead to edema and dysfunction of the intestine. Therefore, monitoring the venous return status is crucial for intestinal perfusion. In 2012, the Venous Excess Ultrasound Score(VExUS) for evaluating venous return has been reported and it has been shown to correlate with acute kidney injury (AKI) \[Intensive Care Med, 2012. 38(3): p.384-94\]. However, there is currently no research on the correlation between acute gastrointestinal injury and venous return, and this study is innovative and exploratory.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 30, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2023
Actual (reported)January 17, 2024
Actual (reported)October 31, 2024
Actual (reported)November 30, 2024
Actual (reported)July 30, 2025
Actual (reported)The Venous Excess Ultrasound Score
The study primary endpoint was the VExUS score. It was calculated four times during the ICU stay: within 24 h of ICU admission, after day 1 (between 24 and 48 h), after day 2 (between 48 and 72 h), and at ICU discharge. The patients were classified as being congestive (VExUS≥2) or not being congestive (VExUS \< 2). A VExUS grade 2 was defined as moderate congestion, and a VExUS grade 3 was defined as severe congestion.
Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)
Serologic indices of intestinal mucosal epithelial injury Plasma citrulline, plasma intestinal fatty acid binding protein, and D-lactic acid
Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)
Acute gastrointestinal injury
Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)
GIDS
Day 1(ICU admission),Day 2(between 24 and 48 h),Day 3(between 48 and 72 h),Departure Day(ICU discharge)
Adult ICU admitted patients in comprehensive hospital
Department of Critical Care Medicine of pekin union medical college hospital
Beijing, Beijing Municipality, 100730, China
200 participants (actual enrollment reported by the registry).
First Submitted
January 17, 2024
First Posted
October 31, 2024
Study Start
May 1, 2023
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
November 30, 2024
Actual (reported)Study Completion
July 30, 2025
Actual (reported)Last Updated
September 5, 2025
Record last verified: 2024-10
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: